Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions
Coronary Heart Disease
Interventions
DRUG

ticagrelor

90 mg bid for 2 weeks

DRUG

Aspirin

100mg Qd for 2 weeks.

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Yong Huo

OTHER

NCT02219412 - Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy | Biotech Hunter | Biotech Hunter